As described already, anti-titin antibodies are found in early onset MG with thymoma and in late-onset MG independent of thymoma presence [1,26]; therefore, so far, measurement of anti-titin antibodies is useful only for early-onset MG patients. The gene discussed is TTN; the disease is myasthenia gravis.